Experts share here what they take away from the Conference on Retroviruses and Opportunistic Infections (CROI) each year and ...

The Conference on Retroviruses and Opportunistic Infections 2025 (CROI) featured multiple sessions that focused on breaking research and treatments.

Spotlight reports on this and some of the other exciting research on long-acting anti-HIV medicines presented at the ...

Ensitrelvir reduced transmission of SARS-CoV-2 by 67% when given to uninfected household contacts of a person with COVID-19 ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

Increasing HPV vaccination rates could help decrease the number of cancer cases “attributable to HIV,” according to data from ...

This year there were empty seats at the prestigious Conference on Retroviruses and Opportunistic Infections, Croi, in San Francisco, where groundbreaking HIV research gets presented. Missing from the ...

Previous research has suggested an increased risk for neuropsychiatric symptoms in people living with HIV who are being ...

AIDS advocates are fearful that budget cuts being pushed by Republicans will gut essential health care services in the United ...

taking ensitrelvir within 72 hours of symptoms is effective at preventing infection and generally well tolerated, according ...

At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full day of the conference, reports from the ...

Gilead Sciences, Inc. (NASDAQ:GILD) presented data from its HIV treatment portfolio and pipeline at the Conference on Retroviruses and Opportunistic Infections (CROI 2025). ALLIANCE is an ongoing ...